Shivani Shinde &Amp; Abhineet Kumar

Stories by Shivani Shinde &Amp; Abhineet Kumar

'Cyber attacks meant to smear India's reputation'

'Cyber attacks meant to smear India's reputation'

Rediff.com   9 Mar 2021

'The hackers' objectives were centred around smearing India's reputation, causing productivity loss, creating operational damage and seeking financial gains.'

E-learning, WFH power up notebook and laptop sales

E-learning, WFH power up notebook and laptop sales

Rediff.com   19 Feb 2021

For Q4CY20, PC shipments grew by 27 per cent year-on-year, said data from the IDC.

At Rs 9500 cr, Tatas' buyout of BigBasket will be biggest in online grocery space

At Rs 9500 cr, Tatas' buyout of BigBasket will be biggest in online grocery space

Rediff.com   17 Feb 2021

The deal, which is expected to close in the next four to five weeks, will give exit to investors Alibaba, Abraaj Group and IFC. The parties are awaiting approval from the Competition Commission of India (CCI).

Xiaomi maintains No.1 position in a bad year for smartphones

Xiaomi maintains No.1 position in a bad year for smartphones

Rediff.com   16 Feb 2021

The first half of the year (H1-2020) was marked by sluggish growth with demand down 26 per cent YoY, while the second half saw recovery. H2-2020 recovered with 19 per cent YoY growth, reports Shivani Shinde.

IT majors to focus on localised hiring

IT majors to focus on localised hiring

Rediff.com   15 Feb 2021

TCS, Infosys ramp up onshore hiring; Infosys committed to hire 25,000 over 5 years.

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com   6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Rediff.com   20 Feb 2018

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales.

Taj takes another U-turn on branding

Taj takes another U-turn on branding

Rediff.com   20 Feb 2018

The multi-brand strategy could drive profitability to a 25% profit margin in the next five years from 17% now.

David vs Goliath: How Wockhardt plans to beat global challenge

David vs Goliath: How Wockhardt plans to beat global challenge

Rediff.com   22 Jan 2018

Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.

Can Reliance be among the world's top 20 companies?

Can Reliance be among the world's top 20 companies?

Rediff.com   11 Jan 2018

The firm would require it to more than triple its CAGR of revenue to 18.5% for the next decade from 6%

Bankruptcy will influence M&A trend in 2018

Bankruptcy will influence M&A trend in 2018

Rediff.com   2 Jan 2018

Banks have Rs 10 trillion in stressed assets - Rs 7.8 trillion of bad loans and Rs 2.2 trillion of restructured ones.

Mental health disorders: India's invisible epidemic

Mental health disorders: India's invisible epidemic

Rediff.com   16 Dec 2017

And the way to a cure begins with conversation.

How India narrowly escaped a health crisis

How India narrowly escaped a health crisis

Rediff.com   5 Dec 2017

The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases.

Why retailers are betting big on small towns

Why retailers are betting big on small towns

Rediff.com   5 Dec 2017

The expansion into smaller towns is coming at a time when the online retail space has not only seen consolidation but is actually looking to collaborate with physical stores. Abhineet Kumar reports.

This is why Godrej is a big name in India's real estate sector

This is why Godrej is a big name in India's real estate sector

Rediff.com   21 Nov 2017

In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year

How Shoppers Stop pulled itself back

How Shoppers Stop pulled itself back

Rediff.com   23 Oct 2017

Shoppers Stop returns to its core business after divestments. The retailer plans growth through web and private labels.

Will Tatas and Ambanis succeed where Birla failed?

Will Tatas and Ambanis succeed where Birla failed?

Rediff.com   3 Oct 2017

As India's online population crosses 450 million, e-commerce ventures are trying to grab a pie of online sales estimated to hit $48 billion by 2020.

How Kishore Biyani got back his magic touch

How Kishore Biyani got back his magic touch

Rediff.com   14 Sep 2017

From the stock perspective, though, even as all the 10 analysts polled by Bloomberg have a 'buy' recommendation on FRL, their target price of Rs 535 suggest most of the positives are already priced in.

Why GSK is changing its strategy after 93 years

Why GSK is changing its strategy after 93 years

Rediff.com   4 Sep 2017

Increased price control over branded generic medicines has affected its profitability

Bombay House to be shut for about a year

Bombay House to be shut for about a year

Rediff.com   7 Aug 2017

Bombay House will be closed for renovation - its first such closure in 93 years